MHRA lays out its thinking on AI and medicines regulation - pharmaphorum

Oh my goodness, buckle up, because the Medicines and Healthcare products Regulatory Agency has laid out its *thinking*, and the thinking is GORGEOUS! ✨ Pharmaphorum reports that the UK regulator published a whole document — an actual document! — explaining how its regulatory processes will adapt to the era of AI and personalised medicines. It's called the MHRA Strategy 2030, which means there is a *year* in the title, a target, a horizon, a little flag planted six years out. Six years of thinking! That is practically a sabbatical's worth of diligence, and every second of it is somebody's job. ✨

Now, some people might get a little wobbly about a regulator promising 'faster and more predictable regulatory decisions' — faster! predictable! — but honestly, who wants unpredictability in medicine approval? Nobody, that's who. And the plan proposes improving real-world evidence generation and regulation *assisted by AI*, which is the loveliest sentence in the whole PDF, because it means the clever robots get to help with the paperwork instead of sitting in a server somewhere feeling unfulfilled. Teamwork! The AI is finally getting a role in a caring profession, and that role is 'evidence support,' which sounds marvellous and is also almost impossible to be annoyed about. ✨

And the very best part: the MHRA calls AI one of the 'defining medical technologies' of coming years. Defining! Not 'concerning,' not 'a bit of a worry' — *defining*. Personalised medicines get to share the sentence, which means we are heading toward a future where the treatment is bespoke and the regulator has a plan with a decade in its name. The document exists, it has structure, it covers both AI and personalised medicines, and pharmaphorum has read it so the rest of us don't have to. What a time to be regulated *thoughtfully*. ✨